Literature DB >> 32159395

Peptide hormones and risk for future cardiovascular events among prediabetics: a 20-year follow-up in the OPERA study.

Olli-Juhani Galla1, Antti Ylitalo2, Antti Kiviniemi1, Heikki Huikuri1, Y Antero Kesäniemi1, Olavi Ukkola1.   

Abstract

Background: Prediabetes has proven to have many unfavourable impacts on the cardiovascular system.
Methods: The OPERA (Oulu Project Elucidating Risk of Atherosclerosis) study included 1045 middle-aged subjects followed from the years 1990-1993 to 2014. The focus was on peptide hormones.
Results: Plasma resistin levels were higher among prediabetics (p = .001), particularly impaired glucose tolerance (IGT) (p < .001), but not impaired fasting glucose (IFG) patients than among normal glucose tolerance (NGT) or diabetes groups. Diabetics showed lower resistin levels than IGT subjects (p < .001). IGT or diabetes groups showed lower adiponectin and higher leptin levels compared to the NGT group (p < .001). The IFG group had the highest blood pressure and left ventricular mass index, even higher than the diabetic group. Diabetics had the highest, prediabetics (IFG + IGT) intermediate and NGT the lowest risk for CVD events during follow-up (p < .001). Among prediabetics, high plasma ghrelin was an independent predictor of CVD events (p < .05) in the Cox regression analysis although it did not significantly improve either classification or discrimination of the patients.Conclusions: Among glucose tolerance groups, patients with IGT had the highest resistin, but equally high leptin and low adiponectin levels as diabetics. Among prediabetics, ghrelin seems to predict independently cardiovascular events in the long term.KEY MESSAGEAmong glucose tolerance groups, patients with IGT had the highest resistin, but equally high leptin and low adiponectin levels as diabetics.Among prediabetics, ghrelin seems to predict independently cardiovascular events in the long term.

Entities:  

Keywords:  Prediabetes; cardiovascular disease; peptide hormones

Year:  2020        PMID: 32159395      PMCID: PMC7877964          DOI: 10.1080/07853890.2020.1741673

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  23 in total

Review 1.  Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.

Authors:  Chenxiao Liu; Xiu Feng; Qi Li; Ying Wang; Qian Li; Majian Hua
Journal:  Cytokine       Date:  2016-08-04       Impact factor: 3.861

Review 2.  Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine.

Authors:  Katharina Nimptsch; Stefan Konigorski; Tobias Pischon
Journal:  Metabolism       Date:  2018-12-23       Impact factor: 8.694

3.  Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up.

Authors:  Tero J W Pääkkö; Reko J Renko; Juha S Perkiömäki; Y Antero Kesäniemi; Antti S Ylitalo; Jarmo A Lumme; Heikki V Huikuri; Heikki Ruskoaho; Olli Vuolteenaho; Olavi H Ukkola
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

Review 4.  Ghrelin and atherosclerosis.

Authors:  Olavi Ukkola
Journal:  Curr Opin Lipidol       Date:  2015-08       Impact factor: 4.776

5.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 6.  Prediabetes and associated disorders.

Authors:  Martin Buysschaert; José Luís Medina; Michael Bergman; Avni Shah; Jaqueline Lonier
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

7.  Body fat measured by a near-infrared interactance device as a predictor of cardiovascular events: the FINRISK'92 cohort.

Authors:  Pia Pajunen; Pekka Jousilahti; Katja Borodulin; Kennet Harald; Jaakko Tuomilehto; Veikko Salomaa
Journal:  Obesity (Silver Spring)       Date:  2010-10-21       Impact factor: 5.002

8.  Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells.

Authors:  Wei Gen Li; Dan Gavrila; Xuebo Liu; Lixing Wang; Skuli Gunnlaugsson; Lynn L Stoll; Michael L McCormick; Curt D Sigmund; Chaosu Tang; Neal L Weintraub
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

Review 9.  Prediabetes: a high-risk state for diabetes development.

Authors:  Adam G Tabák; Christian Herder; Wolfgang Rathmann; Eric J Brunner; Mika Kivimäki
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

10.  Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

Authors:  Gianluca Baldanzi; Nicoletta Filigheddu; Santina Cutrupi; Filomena Catapano; Sara Bonissoni; Alberto Fubini; Daniela Malan; Germano Baj; Riccarda Granata; Fabio Broglio; Mauro Papotti; Nicola Surico; Federico Bussolino; Jorgen Isgaard; Romano Deghenghi; Fabiola Sinigaglia; Maria Prat; Giampiero Muccioli; Ezio Ghigo; Andrea Graziani
Journal:  J Cell Biol       Date:  2002-12-16       Impact factor: 10.539

View more
  1 in total

1.  Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

Authors:  Dongli Han; Jie Chen; Shousheng Liu; Zengzhi Zhang; Zhenzhen Zhao; Wenwen Jin; Yongning Xin
Journal:  J Clin Transl Hepatol       Date:  2021-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.